A body-composition support IV designed to complement weight-management efforts, metabolic efficiency, and fat metabolism
Hence, one of the questions that remains to be clearly answered is whether the reported GSH decrease in IBD is an epiphenomenon of colitis or if GSH depletion plays any pathophysiological role in the development of colitis
Yan H, Ma H, Li Y, Zhao L, Lin J, Jia Q, Hu Q, Han D
Additionally, data from a Phase I clinical trial (NCT02861300) indicated that the combination of CB-839 and capecitabine which is a prodrug of 5-FU, was well tolerated by CRC patients at bioactive doses
Purity is paramount because any contaminants or incorrect amino acid sequences can drastically alter research outcomes, produce unreliable data, or cause unexpected side effects
1 2 The American Journal of Clinical Nutrition